NanoCarrier Co., Ltd.
NanoCarrier Co., Ltd. (4571.T) Stock Competitors & Peer Comparison
See (4571.T) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 4571.T | ¥144.00 | +2.86% | 10B | -11.91 | -¥11.84 | N/A |
| 4587.T | ¥1,676.00 | +0.42% | 217.8B | 14.77 | ¥114.16 | N/A |
| 4592.T | ¥2,445.00 | +4.71% | 179.7B | -40.82 | -¥61.12 | N/A |
| 2160.T | ¥2,913.00 | +2.57% | 147.7B | -163.46 | -¥17.87 | N/A |
| 4974.T | ¥917.00 | +1.21% | 110.3B | 106.39 | ¥8.61 | +1.86% |
| 4565.T | ¥880.00 | -4.45% | 85.2B | -36.71 | -¥25.66 | N/A |
| 4593.T | ¥642.00 | +3.22% | 70.6B | -14.17 | -¥45.53 | N/A |
| 4894.T | ¥6,100.00 | +0.00% | 50.4B | -76.25 | -¥80.52 | N/A |
| 4889.T | ¥3,015.00 | +3.86% | 35.4B | 309.44 | ¥9.00 | N/A |
| 4563.T | ¥71.00 | -4.05% | 25.1B | -0.62 | -¥114.38 | N/A |
Stock Comparison
4571.T vs 4587.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4587.T has a market cap of 217.8B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4587.T trades at ¥1,676.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4587.T's P/E ratio is 14.77. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4587.T's ROE of +0.26%. Regarding short-term risk, 4571.T is less volatile compared to 4587.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4587.T's competition here
4571.T vs 4592.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4592.T has a market cap of 179.7B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4592.T trades at ¥2,445.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4592.T's P/E ratio is -40.82. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4592.T's ROE of -1.82%. Regarding short-term risk, 4571.T is less volatile compared to 4592.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4592.T's competition here
4571.T vs 2160.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 2160.T has a market cap of 147.7B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 2160.T trades at ¥2,913.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 2160.T's P/E ratio is -163.46. In terms of profitability, 4571.T's ROE is -0.28%, compared to 2160.T's ROE of -0.03%. Regarding short-term risk, 4571.T is more volatile compared to 2160.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 2160.T's competition here
4571.T vs 4974.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4974.T has a market cap of 110.3B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4974.T trades at ¥917.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4974.T's P/E ratio is 106.39. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4974.T's ROE of +0.01%. Regarding short-term risk, 4571.T is more volatile compared to 4974.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4974.T's competition here
4571.T vs 4565.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4565.T has a market cap of 85.2B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4565.T trades at ¥880.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4565.T's P/E ratio is -36.71. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4565.T's ROE of -0.03%. Regarding short-term risk, 4571.T is less volatile compared to 4565.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4565.T's competition here
4571.T vs 4593.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4593.T has a market cap of 70.6B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4593.T trades at ¥642.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4593.T's P/E ratio is -14.17. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4593.T's ROE of -1.95%. Regarding short-term risk, 4571.T is less volatile compared to 4593.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4593.T's competition here
4571.T vs 4894.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4894.T has a market cap of 50.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4894.T trades at ¥6,100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4894.T's P/E ratio is -76.25. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4894.T's ROE of -0.12%. Regarding short-term risk, 4571.T is more volatile compared to 4894.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4894.T's competition here
4571.T vs 4889.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4889.T has a market cap of 35.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4889.T trades at ¥3,015.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4889.T's P/E ratio is 309.44. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4889.T's ROE of +0.07%. Regarding short-term risk, 4571.T is less volatile compared to 4889.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4889.T's competition here
4571.T vs 4563.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4563.T has a market cap of 25.1B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4563.T trades at ¥71.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4563.T's P/E ratio is -0.62. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4563.T's ROE of -2.08%. Regarding short-term risk, 4571.T is less volatile compared to 4563.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4563.T's competition here
4571.T vs 7774.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 7774.T has a market cap of 23.6B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 7774.T trades at ¥560.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 7774.T's P/E ratio is -92.37. In terms of profitability, 4571.T's ROE is -0.28%, compared to 7774.T's ROE of -0.04%. Regarding short-term risk, 4571.T is less volatile compared to 7774.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 7774.T's competition here
4571.T vs 4599.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4599.T has a market cap of 20.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4599.T trades at ¥332.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4599.T's P/E ratio is -9.81. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4599.T's ROE of -0.24%. Regarding short-term risk, 4571.T is more volatile compared to 4599.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4599.T's competition here
4571.T vs 4978.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4978.T has a market cap of 20.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4978.T trades at ¥218.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4978.T's P/E ratio is 193.69. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4978.T's ROE of +0.01%. Regarding short-term risk, 4571.T is more volatile compared to 4978.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4978.T's competition here
4571.T vs 4575.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4575.T has a market cap of 20.1B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4575.T trades at ¥1,033.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4575.T's P/E ratio is -14.28. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4575.T's ROE of -0.36%. Regarding short-term risk, 4571.T is more volatile compared to 4575.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4575.T's competition here
4571.T vs 7776.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 7776.T has a market cap of 16.6B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 7776.T trades at ¥484.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 7776.T's P/E ratio is -18.64. In terms of profitability, 4571.T's ROE is -0.28%, compared to 7776.T's ROE of -0.49%. Regarding short-term risk, 4571.T is more volatile compared to 7776.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 7776.T's competition here
4571.T vs 4588.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4588.T has a market cap of 14.7B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4588.T trades at ¥602.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4588.T's P/E ratio is -7.67. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4588.T's ROE of -1.06%. Regarding short-term risk, 4571.T is less volatile compared to 4588.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4588.T's competition here
4571.T vs 4888.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4888.T has a market cap of 14.3B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4888.T trades at ¥421.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4888.T's P/E ratio is -99.53. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4888.T's ROE of -0.05%. Regarding short-term risk, 4571.T is more volatile compared to 4888.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4888.T's competition here
4571.T vs 4880.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4880.T has a market cap of 13.5B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4880.T trades at ¥704.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4880.T's P/E ratio is -265.76. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4880.T's ROE of +0.01%. Regarding short-term risk, 4571.T is less volatile compared to 4880.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4880.T's competition here
4571.T vs 4579.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4579.T has a market cap of 13.1B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4579.T trades at ¥534.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4579.T's P/E ratio is -23.41. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4579.T's ROE of -0.08%. Regarding short-term risk, 4571.T is more volatile compared to 4579.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4579.T's competition here
4571.T vs 4584.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4584.T has a market cap of 12.9B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4584.T trades at ¥256.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4584.T's P/E ratio is -531.37. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4584.T's ROE of -0.02%. Regarding short-term risk, 4571.T is less volatile compared to 4584.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4584.T's competition here
4571.T vs 4875.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4875.T has a market cap of 10.6B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4875.T trades at ¥203.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4875.T's P/E ratio is -6.15. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4875.T's ROE of -0.21%. Regarding short-term risk, 4571.T is more volatile compared to 4875.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4875.T's competition here
4571.T vs 7096.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 7096.T has a market cap of 10.2B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 7096.T trades at ¥1,019.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 7096.T's P/E ratio is 26.70. In terms of profitability, 4571.T's ROE is -0.28%, compared to 7096.T's ROE of +0.14%. Regarding short-term risk, 4571.T is more volatile compared to 7096.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 7096.T's competition here
4571.T vs 2370.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 2370.T has a market cap of 10.1B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 2370.T trades at ¥38.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 2370.T's P/E ratio is -7.36. In terms of profitability, 4571.T's ROE is -0.28%, compared to 2370.T's ROE of -0.27%. Regarding short-term risk, 4571.T is more volatile compared to 2370.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 2370.T's competition here
4571.T vs 4583.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4583.T has a market cap of 9.7B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4583.T trades at ¥143.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4583.T's P/E ratio is -8.10. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4583.T's ROE of -0.66%. Regarding short-term risk, 4571.T is more volatile compared to 4583.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4583.T's competition here
4571.T vs 177A.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 177A.T has a market cap of 9B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 177A.T trades at ¥1,784.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 177A.T's P/E ratio is 11.22. In terms of profitability, 4571.T's ROE is -0.28%, compared to 177A.T's ROE of +0.15%. Regarding short-term risk, 4571.T is more volatile compared to 177A.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 177A.T's competition here
4571.T vs 4564.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4564.T has a market cap of 8.8B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4564.T trades at ¥28.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4564.T's P/E ratio is -9.29. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4564.T's ROE of -1.00%. Regarding short-term risk, 4571.T is less volatile compared to 4564.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4564.T's competition here
4571.T vs 4594.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4594.T has a market cap of 8.5B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4594.T trades at ¥70.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4594.T's P/E ratio is -5.17. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4594.T's ROE of -1.16%. Regarding short-term risk, 4571.T is less volatile compared to 4594.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4594.T's competition here
4571.T vs 4896.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4896.T has a market cap of 8.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4896.T trades at ¥765.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4896.T's P/E ratio is -9.94. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4896.T's ROE of -0.34%. Regarding short-term risk, 4571.T is less volatile compared to 4896.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4896.T's competition here
4571.T vs 3750.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 3750.T has a market cap of 8.2B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 3750.T trades at ¥916.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 3750.T's P/E ratio is -3.86. In terms of profitability, 4571.T's ROE is -0.28%, compared to 3750.T's ROE of -1.14%. Regarding short-term risk, 4571.T is more volatile compared to 3750.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 3750.T's competition here
4571.T vs 4598.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4598.T has a market cap of 8B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4598.T trades at ¥694.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4598.T's P/E ratio is -3.56. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4598.T's ROE of -3.42%. Regarding short-term risk, 4571.T is less volatile compared to 4598.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4598.T's competition here
4571.T vs 2183.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 2183.T has a market cap of 7.6B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 2183.T trades at ¥339.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 2183.T's P/E ratio is -14.08. In terms of profitability, 4571.T's ROE is -0.28%, compared to 2183.T's ROE of -0.07%. Regarding short-term risk, 4571.T is more volatile compared to 2183.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 2183.T's competition here
4571.T vs 4893.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4893.T has a market cap of 7.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4893.T trades at ¥174.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4893.T's P/E ratio is -7.72. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4893.T's ROE of -0.18%. Regarding short-term risk, 4571.T is more volatile compared to 4893.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4893.T's competition here
4571.T vs 4891.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4891.T has a market cap of 7.3B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4891.T trades at ¥160.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4891.T's P/E ratio is -9.77. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4891.T's ROE of -0.22%. Regarding short-term risk, 4571.T is more volatile compared to 4891.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4891.T's competition here
4571.T vs 206A.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 206A.T has a market cap of 6.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 206A.T trades at ¥177.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 206A.T's P/E ratio is -5.00. In terms of profitability, 4571.T's ROE is -0.28%, compared to 206A.T's ROE of -0.40%. Regarding short-term risk, 4571.T is less volatile compared to 206A.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 206A.T's competition here
4571.T vs 4572.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4572.T has a market cap of 6B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4572.T trades at ¥311.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4572.T's P/E ratio is -2.57. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4572.T's ROE of -0.88%. Regarding short-term risk, 4571.T is more volatile compared to 4572.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4572.T's competition here
4571.T vs 4576.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4576.T has a market cap of 5.3B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4576.T trades at ¥113.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4576.T's P/E ratio is -3.19. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4576.T's ROE of -1.24%. Regarding short-term risk, 4571.T is more volatile compared to 4576.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4576.T's competition here
4571.T vs 4570.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4570.T has a market cap of 4.7B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4570.T trades at ¥504.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4570.T's P/E ratio is 18.84. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4570.T's ROE of +0.18%. Regarding short-term risk, 4571.T is more volatile compared to 4570.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4570.T's competition here
4571.T vs 4591.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4591.T has a market cap of 4.5B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4591.T trades at ¥105.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4591.T's P/E ratio is -4.05. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4591.T's ROE of -0.32%. Regarding short-term risk, 4571.T is less volatile compared to 4591.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 4591.T's competition here
4571.T vs 4881.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4881.T has a market cap of 4.5B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4881.T trades at ¥110.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4881.T's P/E ratio is -3.50. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4881.T's ROE of -0.54%. Regarding short-term risk, 4571.T is more volatile compared to 4881.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4881.T's competition here
4571.T vs 2385.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 2385.T has a market cap of 4.3B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 2385.T trades at ¥165.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 2385.T's P/E ratio is -10.88. In terms of profitability, 4571.T's ROE is -0.28%, compared to 2385.T's ROE of -0.04%. Regarding short-term risk, 4571.T is more volatile compared to 2385.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 2385.T's competition here
4571.T vs 4884.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4884.T has a market cap of 3.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4884.T trades at ¥499.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4884.T's P/E ratio is -3.79. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4884.T's ROE of -0.45%. Regarding short-term risk, 4571.T is more volatile compared to 4884.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4884.T's competition here
4571.T vs 2342.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 2342.T has a market cap of 3.4B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 2342.T trades at ¥201.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 2342.T's P/E ratio is -3.19. In terms of profitability, 4571.T's ROE is -0.28%, compared to 2342.T's ROE of -0.20%. Regarding short-term risk, 4571.T is less volatile compared to 2342.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 2342.T's competition here
4571.T vs 4596.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 4596.T has a market cap of 3B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 4596.T trades at ¥50.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 4596.T's P/E ratio is -2.07. In terms of profitability, 4571.T's ROE is -0.28%, compared to 4596.T's ROE of -0.79%. Regarding short-term risk, 4571.T is more volatile compared to 4596.T. This indicates potentially higher risk in terms of short-term price fluctuations for 4571.T.Check 4596.T's competition here
4571.T vs 6190.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 6190.T has a market cap of 1.9B. Regarding current trading prices, 4571.T is priced at ¥144.00, while 6190.T trades at ¥434.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 6190.T's P/E ratio is -4.13. In terms of profitability, 4571.T's ROE is -0.28%, compared to 6190.T's ROE of -0.27%. Regarding short-term risk, 4571.T is less volatile compared to 6190.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 6190.T's competition here
4571.T vs 2191.T Comparison August 2025
4571.T plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 4571.T stands at 10B. In comparison, 2191.T has a market cap of 0. Regarding current trading prices, 4571.T is priced at ¥144.00, while 2191.T trades at ¥2.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
4571.T currently has a P/E ratio of -11.91, whereas 2191.T's P/E ratio is -0.06. In terms of profitability, 4571.T's ROE is -0.28%, compared to 2191.T's ROE of -1.44%. Regarding short-term risk, 4571.T is less volatile compared to 2191.T. This indicates potentially lower risk in terms of short-term price fluctuations for 4571.T.Check 2191.T's competition here